IPD vs REG

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IPD

IMPEDIMED FPO [IPD]

48LOW

REG

REG HEALTH FPO [REG]

40LOW

Score Breakdown

IPD REG
Technical
57
51
Catalyst
55
62
Sentiment
50
50
Fundamental
95
94
Momentum
30
51
Risk Gate
27
50

Key Metrics

IPD Metric REG
$22.0MMarket Cap$1.8B
6.9MAvg Volume (20d)818K
N/AShort Interest+1.4%
$0.05952-Week High$9.400
$0.00552-Week Low$5.620
+0.0%Daily Change-1.2%
$0.006Reference Price$6.085
-117.9%ROEN/A
-171.3%Profit Margin+3.0%

Active Signals

IPD Signals

Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (5 quarters)
Low P/S ratio (1.5x)
Strong revenue growth (+25%)
Piotroski F-Score weak (3/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Near 52-week low (2% of range)

REG Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.1% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.5x)

Ask Scout AI to compare IPD and REG in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IPD vs RHY →LDX vs MVP →LDX vs NAN →LDX vs NTI →LDX vs NYR →
IPD Full Analysis → REG Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).